Jabłońska E, Pietruska Z
Department of Immunopathology, University Medical School, Białystok, Poland.
Arch Immunol Ther Exp (Warsz). 1997;45(5-6):449-53.
The release of soluble tumor necrosis factor receptors (sTNF-Rs): soluble tumor necrosis factor receptor I (sTNF-RI) and soluble tumor necrosis factor receptor II (sTNF-RII) by polymorphonuclear cells (PMNs) derived from patients with breast cancer were measured. Serum levels of sTNF-RII and sTNF-RII in patients group were also determined. Significantly higher values of sTNF-RI and sTNF-RII released by PMNs of patients were observed than those in the healthy subjects. There was no significant differences in the serum levels of sTNF-RI and sTNF-RII between breast cancer patients and healthy control. Presented study demostrate that the tumor bearing state, involving breast cancer, may induce an altered soluble cytokine receptors release from the peripheral blood PMNs characterized by increased concentrations of sTNF-RI and sTNF-RII in the culture supernatants of these cells in vitro.
对乳腺癌患者来源的多形核细胞(PMN)释放可溶性肿瘤坏死因子受体(sTNF-Rs):可溶性肿瘤坏死因子受体I(sTNF-RI)和可溶性肿瘤坏死因子受体II(sTNF-RII)的情况进行了测定。同时还测定了患者组血清中sTNF-RII和sTNF-RII的水平。观察到患者PMN释放的sTNF-RI和sTNF-RII的值显著高于健康受试者。乳腺癌患者和健康对照者血清中sTNF-RI和sTNF-RII的水平没有显著差异。本研究表明,包括乳腺癌在内的肿瘤状态可能会诱导外周血PMN释放可溶性细胞因子受体发生改变,其特征是这些细胞体外培养上清液中sTNF-RI和sTNF-RII的浓度增加。